• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肾贫血综合征预测腹膜透析患者的生存。

The cardio-renal-anaemia syndrome predicts survival in peritoneally dialyzed patients.

机构信息

Department of Nephrology and Transplantology, Medical University, Bialystok, Poland.

出版信息

Arch Med Sci. 2010 Aug 30;6(4):539-44. doi: 10.5114/aoms.2010.14465. Epub 2010 Sep 7.

DOI:10.5114/aoms.2010.14465
PMID:22371797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3284068/
Abstract

INTRODUCTION

Anaemia is one of the arms of the cardio-renal-anaemia syndrome (CRA) in chronic kidney disease (CKD) patients. The correction of anaemia was effective in the amelioration of both cardiac and renal failure. We studied the relationship between the severity of CRA syndrome in peritoneally dialyzed patients and their survival probability.

MATERIAL AND METHODS

Fifty-six patients on peritoneal dialysis were followed for 1 year. Definition of the severity of the CRA in dialysis patients: cardiac arm - NYHA class I-IV = 1-4 points, renal arm - non-diabetic patients age < 65 =1 point, non-diabetic patients age>65 = 2 points, diabetic patients age < 65 = 3 points, diabetic patients age>65 = 4 points, anaemia arm - Hb 11-13 g/dl (male), 11-12 g/dl (female) = 1 point, Hb 10-11 g/dl = 2 points, Hb 9-10 g/dl = 3 points, Hb < 9 g/dl = 4 points. The severity score = cardiac + renal + anaemia arms score divided by 3 (maximum 4 points).

RESULTS

A total of 10/56 patients (18%) died during the study. The median value for the severity score of the whole group was 1.69. In Kaplan-Meier analysis CRA severity score was strongly associated with mortality (p < 0.001). It also correlated with albumin, CRP, erythropoietin treatment, Hb and fasting glucose. In the multivariate regression analysis age, Hb, albumin, and presence of diabetes remained significant predictors of death.

CONCLUSIONS

The severity score of CRA syndrome in peritoneally dialyzed patients is an independent and very significant predictor of death. The patients with a high severity score had more hypoalbuminaemia, higher inflammation markers and higher prevalence of diabetes and chronic heart failure. Cardio-renal-anaemia syndrome severity scoring as defined by us could be an easy tool to predict outcome of dialysis patients.

摘要

简介

贫血是慢性肾脏病(CKD)患者心肾贫血综合征(CRA)的一个分支。贫血的纠正对于改善心脏和肾脏衰竭均有效。我们研究了腹膜透析患者中 CRA 综合征的严重程度与他们的生存概率之间的关系。

材料和方法

对 56 名接受腹膜透析的患者进行了为期 1 年的随访。定义透析患者 CRA 严重程度:心脏臂-NYHA 分级 I-IV=1-4 分,肾脏臂-非糖尿病患者年龄<65=1 分,非糖尿病患者年龄>65=2 分,糖尿病患者年龄<65=3 分,糖尿病患者年龄>65=4 分,贫血臂-Hb11-13g/dl(男性),11-12g/dl(女性)=1 分,Hb10-11g/dl=2 分,Hb9-10g/dl=3 分,Hb<9g/dl=4 分。严重程度评分=心脏+肾脏+贫血臂评分除以 3(最高 4 分)。

结果

在研究期间,共有 10/56 名患者(18%)死亡。整个组的严重程度评分中位数为 1.69。在 Kaplan-Meier 分析中,CRA 严重程度评分与死亡率密切相关(p<0.001)。它还与白蛋白、CRP、促红细胞生成素治疗、Hb 和空腹血糖相关。在多变量回归分析中,年龄、Hb、白蛋白和糖尿病的存在仍然是死亡的显著预测因素。

结论

腹膜透析患者 CRA 综合征的严重程度评分是死亡的独立且非常重要的预测因素。严重程度评分较高的患者白蛋白水平较低、炎症标志物水平较高、糖尿病和慢性心力衰竭的患病率较高。我们定义的 CRA 综合征严重程度评分可能是预测透析患者预后的一种简单工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff47/3284068/64f6361727bd/AMS-6-15176-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff47/3284068/64f6361727bd/AMS-6-15176-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff47/3284068/64f6361727bd/AMS-6-15176-g001.jpg

相似文献

1
The cardio-renal-anaemia syndrome predicts survival in peritoneally dialyzed patients.心肾贫血综合征预测腹膜透析患者的生存。
Arch Med Sci. 2010 Aug 30;6(4):539-44. doi: 10.5114/aoms.2010.14465. Epub 2010 Sep 7.
2
Over-representation of diabetic patients with renal anaemia in the primary care setting.基层医疗环境中合并肾性贫血的糖尿病患者比例过高。
Fam Pract. 2009 Jun;26(3):180-2. doi: 10.1093/fampra/cmp009. Epub 2009 Mar 2.
3
Efficacy of C.E.R.A. in Routine Clinical Practice for Correction of Anaemia and Maintenance of the Haemoglobin Levels in CKD Patients not on Dialysis.在非透析慢性肾脏病患者中,C.E.R.A.在纠正贫血和维持血红蛋白水平的常规临床实践中的疗效。
J Assoc Physicians India. 2017 Mar;65(3):52-57.
4
Every-other-week darbepoetin alfa in the correction and maintenance of haemoglobin levels in elderly patients with chronic kidney disease: post hoc subanalysis of data from two clinical trials.每两周一次达贝泊汀α在老年慢性肾脏病患者血红蛋白水平的纠正和维持中的应用:两项临床试验数据的事后亚组分析。
Drugs Aging. 2009;26(8):665-75. doi: 10.2165/11316450-000000000-00000.
5
Effect of achieved hemoglobin level on renal outcome in non-dialysis chronic kidney disease (CKD) patients receiving epoetin beta pegol: MIRcerA CLinical Evidence on Renal Survival in CKD patients with renal anemia (MIRACLE-CKD Study).达到的血红蛋白水平对接受聚乙二醇化促红细胞生成素β的非透析慢性肾脏病(CKD)患者肾脏转归的影响:CKD合并肾性贫血患者肾脏生存的MIRcerA临床证据(MIRACLE-CKD研究)
Clin Exp Nephrol. 2019 Mar;23(3):349-361. doi: 10.1007/s10157-018-1649-0. Epub 2018 Oct 5.
6
Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia.一项随机、双盲、安慰剂对照研究,旨在评估两种剂量方案的阿法达贝泊汀对心力衰竭伴贫血患者的疗效。
Eur Heart J. 2007 Sep;28(18):2208-16. doi: 10.1093/eurheartj/ehm328. Epub 2007 Aug 6.
7
UK Renal Registry 11th Annual Report (December 2008): Chapter 9 Haemoglobin, ferritin and erythropoietin amongst patients receiving dialysis in the UK in 2007: national and centre-specific analyses.英国肾脏注册机构第11次年度报告(2008年12月):第9章 2007年英国接受透析治疗患者的血红蛋白、铁蛋白和促红细胞生成素:全国及各中心具体分析
Nephron Clin Pract. 2009;111 Suppl 1:c149-83. doi: 10.1159/000209998. Epub 2009 Mar 26.
8
UK Renal Registry 15th annual report: Chapter 6 haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2011: national and centre-specific analyses.英国肾脏登记处第 15 次年度报告:2011 年英国成年透析患者的血红蛋白、铁蛋白和促红细胞生成素:全国和中心特异性分析。
Nephron Clin Pract. 2013;123 Suppl 1:125-50. doi: 10.1159/000353325. Epub 2013 Jun 10.
9
Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.静脉补铁治疗未透析慢性肾衰竭患者贫血
Nephrol Dial Transplant. 2006 Jan;21(1):120-4. doi: 10.1093/ndt/gfi087. Epub 2005 Sep 6.
10
Darbepoetin alfa once monthly corrects anaemia in patients with chronic kidney disease not on dialysis.聚乙二醇化促红细胞生成素α每月一次可纠正未接受透析的慢性肾病患者的贫血。
Nephrology (Carlton). 2014 May;19(5):266-74. doi: 10.1111/nep.12214.

引用本文的文献

1
Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease.慢性肾脏病患者的非 ST 段抬高型心肌梗死和 ST 段抬高型心肌梗死的治疗。
Arch Med Sci. 2013 Dec 30;9(6):1019-27. doi: 10.5114/aoms.2013.39792. Epub 2013 Dec 26.
2
Correlation between ICAM1 and VCAM1 gene polymorphisms and histopathological changes in kidney allograft biopsies.细胞间黏附分子 1 和血管细胞黏附分子 1 基因多态性与肾移植活检组织病理变化的相关性。
Arch Med Sci. 2013 Apr 20;9(2):276-82. doi: 10.5114/aoms.2012.29218. Epub 2012 Jun 28.
3
Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology.

本文引用的文献

1
The anemia of heart failure.心力衰竭性贫血
Acta Haematol. 2009;122(2-3):109-19. doi: 10.1159/000243795. Epub 2009 Nov 10.
2
2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation.2009年重点更新内容纳入《美国心脏病学会/美国心脏协会2005年成人心力衰竭诊断与管理指南》:美国心脏病学基金会/美国心脏协会实践指南工作组与国际心肺移植学会合作制定的报告
J Am Coll Cardiol. 2009 Apr 14;53(15):e1-e90. doi: 10.1016/j.jacc.2008.11.013.
3
2010 至 2012 年肌肉减少症和恶病质的机制和治疗研究要点及其与心脏病学的相关性。
Arch Med Sci. 2013 Feb 21;9(1):166-71. doi: 10.5114/aoms.2013.33356.
4
Prevention of sudden cardiac death in patients with chronic kidney disease.慢性肾脏病患者的心脏性猝死预防。
BMC Nephrol. 2012 Dec 3;13:162. doi: 10.1186/1471-2369-13-162.
5
Lipids, blood pressure, kidney - what was new in 2011?血脂、血压、肾脏——2011 年有哪些新进展?
Arch Med Sci. 2011 Dec 31;7(6):1055-66. doi: 10.5114/aoms.2011.26620. Epub 2011 Dec 30.
6
Assessing renal function - searching for the perfect marker continues!评估肾功能——寻找完美标志物的征程仍在继续!
Arch Med Sci. 2011 Aug;7(4):565-7. doi: 10.5114/aoms.2011.24120. Epub 2011 Sep 2.
7
Erythropoietin update 2011.2011 年促红细胞生成素更新
Med Sci Monit. 2011 Nov;17(11):RA240-247. doi: 10.12659/msm.882037.
8
Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: preliminary results.腰围、胃饥饿素和部分脂肪组织来源的脂肪因子作为肥胖患者胰岛素抵抗的预测指标:初步研究结果。
Med Sci Monit. 2011 Nov;17(11):PR13-18. doi: 10.12659/msm.882030.
Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease.
谁应该成为慢性肾脏病筛查的目标人群?糖尿病、高血压和心血管疾病的影响。
Am J Kidney Dis. 2009 Mar;53(3 Suppl 3):S71-7. doi: 10.1053/j.ajkd.2008.07.057.
4
The cardio-renal anemia syndrome.心肾贫血综合征
Med Pregl. 2007;60 Suppl 2:145-50.
5
Anemia and chronic heart failure implications and treatment options.贫血与慢性心力衰竭:影响及治疗选择
J Am Coll Cardiol. 2008 Aug 12;52(7):501-11. doi: 10.1016/j.jacc.2008.04.044.
6
Rio de La Plata study: a multicenter, cross-sectional study on cardiovascular risk factors and heart failure prevalence in peritoneal dialysis patients in Argentina and Uruguay.拉普拉塔河研究:一项关于阿根廷和乌拉圭腹膜透析患者心血管危险因素及心力衰竭患病率的多中心横断面研究。
Kidney Int Suppl. 2008 Apr(108):S159-64. doi: 10.1038/sj.ki.5002618.
7
Anaemia in heart failure: a common interaction with renal insufficiency called the cardio-renal anaemia syndrome.心力衰竭中的贫血:一种与肾功能不全的常见相互作用,称为心肾贫血综合征。
Int J Clin Pract. 2008 Feb;62(2):281-6. doi: 10.1111/j.1742-1241.2007.01650.x. Epub 2007 Dec 11.
8
Risk factors for vascular complications in patients on peritoneal dialysis.腹膜透析患者血管并发症的危险因素。
Adv Perit Dial. 2006;22:192-7.
9
Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists.贫血、慢性肾病和充血性心力衰竭——心肾贫血综合征:心脏病学家和肾病学家合作的必要性。
Int Urol Nephrol. 2006;38(2):295-310. doi: 10.1007/s11255-006-0064-8.
10
Survival on chronic dialysis: 10 years' experience of a single Colombian center.慢性透析患者的生存情况:哥伦比亚单一中心的10年经验。
Adv Perit Dial. 2005;21:164-7.